- ISIN
- CA92663R1055
- CUSIP
- 92663R105
- Sector
- Healthcare
- Industry
- Medical Devices
- IPO Date
- Dec 22, 2017
Highlights
- Market Cap
- $442.97M
- Enterprise Value
- $447.72M
- EPS (TTM)
- $0.37
- PE Ratio
- 29.80
- PEG Ratio
- 1.42
- Total Revenue (TTM)
- $286.57M
- Gross Profit (TTM)
- $163.52M
- EBITDA (TTM)
- $46.09M
- Year Range
- $5.93 - $11.04
- ROA (TTM)
- 10.09%
- ROE (TTM)
- 10.35%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
VMD Performance Chart
Viemed Healthcare Inc (VMD) is up 47.2% since the beginning of the year. At $11 per share, VMD is trading just below its 52-week high of $11. Investors who bought $1,000 worth of VMD shares 5 years ago would now be looking at an investment worth $1,497.
Loading charts...
Returns By Period
Viemed Healthcare Inc (VMD) has returned 47.24% so far this year and 64.02% over the past 12 months.
Viemed Healthcare Inc
- 1D
- 0.64%
- 1M
- 13.37%
- YTD
- 47.24%
- 6M
- 50.07%
- 1Y
- 64.02%
- 3Y*
- 5.94%
- 5Y*
- 8.40%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -1.44%
- 1M
- -1.45%
- YTD
- 7.60%
- 6M
- 6.59%
- 1Y
- 22.24%
- 3Y*
- 19.20%
- 5Y*
- 11.54%
- 10Y*
- 13.71%
VMD Monthly Returns History
Based on dividend-adjusted daily data since Jan 4, 2018, VMD's average daily return is +0.15%, while the average monthly return is +2.83%. At this rate, an investment would double in approximately 2.1 years.
Historically, 59% of months were positive and 41% were negative. The best month was Jul 2022 with a return of +45.9%, while the worst month was Nov 2018 at -40.2%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 6 months.
On a daily basis, VMD closed higher 50% of trading days. The best single day was Jan 11, 2019 with a return of +33.3%, while the worst single day was Nov 20, 2018 at -32.6%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 3.23% | 13.43% | 5.86% | 8.14% | -1.20% | 11.18% | 47.24% | ||||||
| 2025 | 2.12% | -4.27% | -7.14% | -2.88% | -5.94% | 3.91% | -11.87% | 21.02% | -7.87% | -4.86% | 6.97% | 7.53% | -7.36% |
| 2024 | 3.44% | 4.19% | 11.47% | -13.15% | -9.52% | -11.61% | 10.08% | 5.41% | -3.55% | 16.64% | 1.40% | -7.50% | 2.17% |
| 2023 | 12.30% | 8.60% | 4.77% | 12.32% | -12.17% | 2.62% | -13.60% | -6.39% | -14.92% | -6.24% | 23.14% | 1.03% | 3.84% |
| 2022 | -11.30% | -17.06% | 29.69% | -0.00% | 15.26% | -6.27% | 45.91% | -24.46% | 1.18% | 9.17% | 12.06% | 3.00% | 44.83% |
| 2021 | 8.12% | 12.40% | 7.32% | -0.59% | -22.37% | -8.45% | -2.66% | -7.90% | -13.42% | 3.24% | -11.87% | 3.37% | -32.73% |
Benchmark Metrics
Viemed Healthcare Inc has an annualized alpha of 33.71%, beta of 0.71, and R2 of 0.06 versus S&P 500 Index. Calculated based on daily prices since January 04, 2018.
- This stock captured 147.61% of S&P 500 Index gains and 100.98% of its losses - amplifying both gains and losses, but participating more in upside than downside.
- R2 of 0.06 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 33.71%
- Beta
- 0.71
- R²
- 0.06
- Upside Capture
- 147.61%
- Downside Capture
- 100.98%
Return for Risk
Risk / Return Rank
VMD ranks 84 for risk / return — in the top 84% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Viemed Healthcare Inc (VMD) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| VMD | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.10 | ||
| Sortino ratioReturn per unit of downside risk | -0.26 | ||
| Omega ratioGain probability vs. loss probability | 1.30 | 1.32 | -0.02 |
| Calmar ratioReturn relative to maximum drawdown | 3.77 | 2.46 | +1.31 |
| Martin ratioReturn relative to average drawdown | 9.36 | 10.92 | -1.56 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Viemed Healthcare Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Viemed Healthcare Inc was 69.35%, occurring on Mar 7, 2022. Recovery took 283 trading sessions.
The current Viemed Healthcare Inc drawdown is 7.05%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
Bear market2022 | -69.35%Mar 2022 | 1y 8mo | 1y 1mo | 2y 10moJun 2020 - Apr 2023 |
COVID crash2020 | -68.13%Mar 2020 | 4mo 26d | 2mo 17d | 7mo 13dOct 2019 - Jun 2020 |
Rate-hike selloffLate 2018 | -51.28%Nov 2018 | 1mo 3d | 5mo 28d | 7mo 1dOct 2018 - May 2019 |
2025 bear market2025 | -49.62%Aug 2025 | 2y 3mo | — | 3y 2moApr 2023 - now |
2018 bear market2018 | -23.76%Jun 2018 | 1mo 4d | 1mo 26d | 3moMay 2018 - Aug 2018 |
Drawdown Indicators
| VMD | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.35% | -56.78% | -12.57% |
Max Drawdown (1Y)Largest decline over 1 year | -17.06% | -9.10% | -7.96% |
Max Drawdown (3Y)Largest decline over 3 years | -40.64% | -18.90% | -21.74% |
Max Drawdown (5Y)Largest decline over 5 years | -52.27% | -25.43% | -26.84% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -7.05% | -3.21% | -3.84% |
Average DrawdownAverage peak-to-trough decline | -29.38% | -10.71% | -18.67% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.86% | 2.04% | +4.82% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Viemed Healthcare Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Viemed Healthcare Inc is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for VMD, comparing it with other companies in the Medical Devices industry. Currently, VMD has a P/E ratio of 29.8. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for VMD compared to other companies in the Medical Devices industry. VMD currently has a PEG ratio of 1.4. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for VMD relative to other companies in the Medical Devices industry. Currently, VMD has a P/S ratio of 1.5. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for VMD in comparison with other companies in the Medical Devices industry. Currently, VMD has a P/B value of 3.1. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with VMD
Add Viemed Healthcare Inc to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with VMD